title: Celiac disease treatment: gluten-free diet and beyond.
abstract: The basis for celiac disease (CD) treatment is a strict lifelong gluten-free diet. On the diet, the small intestinal mucosal injury heals and gluten-induced symptoms and signs disappear. The mucosal healing is a prerequisite for sustaining health and is also obtained with a diet containing oats and trace amounts of gluten, industrially purified wheat starch-based gluten-free products. The small intestinal mucosa does not heal in noncompliant people, nor when a patient is inadvertently ingesting gluten. Development of adjunctive or alternative therapies is on its way. There are several novel treatment pipelines within academy and industry. Examples are the ideas of using glutenases as a drug to degrade the ingested gluten, polymers to bind and sequester the gluten to the feces, and also vaccine development for an immunotherapy to induce tolerance towards gluten. Clinical drug trials are to be foreseen in CD, soon also in children.
authors: Tampere Center for Child Health Research, University of Tampere and Tampere, University Hospital, Tampere, Finland.
authors: Markku
authors: M
authors: Mäki
mesh_terms: D002446:Celiac Disease / Q000628:therapy*; D055050:Diet, Gluten-Free; D005983:Glutens / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007167:Immunotherapy; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology; D010447:Peptide Hydrolases / Q000627:therapeutic use; D011108:Polymers / Q000627:therapeutic use
chemical_list: D011108:Polymers; D005983:Glutens; D010447:Peptide Hydrolases